DekaBank Deutsche Girozentrale
ITOS

DekaBank Deutsche Girozentrale’s iTeos Therapeutics ITOS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,300
Closed -$149K – 1283
2023
Q1 		$149K Hold
11,300
– – ﹤0.01% 1224
2022
Q4 		$220K Hold
11,300
– – ﹤0.01% 1207
2022
Q3 		$215K Hold
11,300
– – ﹤0.01% 1215
2022
Q2 		$227K Hold
11,300
– – ﹤0.01% 1165
2022
Q1 		$361K Buy
11,300
+1,000
+10% +$36.3K ﹤0.01% 1118
2021
Q4 		$475K Buy
10,300
+300
+3% +$9.99K ﹤0.01% 1108
2021
Q3 		$256K Hold
10,000
– – ﹤0.01% 1161
2021
Q2 		$250K Hold
10,000
– – ﹤0.01% 1177
2021
Q1 		$324K Hold
10,000
– – ﹤0.01% 1104
2020
Q4 		$330K Buy
+10,000
New +$265K ﹤0.01% 1108

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ITOS Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of iTeos Therapeutics (ITOS) in Q2 2023, closing a stake of 11,300 shares — an estimated $149K sold.

DekaBank Deutsche Girozentrale first reported a position in ITOS in Q4 2020 and held it in 10 quarters. The position peaked at $475K in Q4 2021. 146 funds tracked by Wall St. Rank hold ITOS as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining iTeos Therapeutics position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 11,300 iTeos Therapeutics shares in Q2 2023, an estimated $149K.
  • DekaBank Deutsche Girozentrale first reported a position in iTeos Therapeutics in Q4 2020 and held it in 10 quarters.
  • DekaBank Deutsche Girozentrale's iTeos Therapeutics position peaked at $475K in Q4 2021.
  • 146 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.